Quantcast
Last updated on April 16, 2014 at 12:17 EDT

Latest Diabetes Stories

2014-03-05 10:42:02

Higher BMI raises risk of type 2 diabetes, high blood pressure Two recent genetic studies expand the list of genes involved with body fat and body mass index, and their connection to major Western health problems: heart disease, high blood pressure and diabetes. One study showed that higher body mass index (BMI) caused harmful effects on the risk of type 2 diabetes, high blood pressure and inflammation, while another study found gene signals linked to higher levels of body fat metrics,...

2014-03-05 08:30:37

The de Beaumont Foundation, Duke Community and Family Medicine, and the CDC Launch "Practical Playbook" Initiative to Integrate Public Health and Primary Care WASHINGTON, March 5, 2014 /PRNewswire/ -- For decades, the medical and public health communities have struggled to stem the rise of illnesses that have led to a dramatic decline in population health. Today, chronic diseases such as asthma, obesity, heart disease, and diabetes have replaced acute diseases like polio and smallpox...

2014-03-05 08:28:11

ALBANY, New York, March 5, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global continuous glucose monitoring market was valued at USD 0.37 billion in 2012 and is expected...

2014-03-04 23:21:59

A Collaboration Focused on the Continued Development of Diabetes and Obesity Breakthroughs Cleveland, OH (PRWEB) March 04, 2014 Diasome Pharmaceuticals, Inc. (http://www.diasome.com) has announced that it has entered into an exclusive investment advisory engagement with McDonald Partners LLC, (http://www.mcdonald-partners.com) a Cleveland, Ohio company that provides full service brokerage, financial advisory and investment banking services to individual, institutional and corporate...

2014-03-03 23:01:36

The Firm is investigating Lipitor lawsuits on behalf of individuals who allegedly developed new-onset Type 2 diabetes due to their use of Lipitor. New York, New York (PRWEB) March 03, 2014 As Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) alleging use of the popular cholesterol-lowering medication continue to move forward in federal court, Bernstein Liebhard LLP notes that Pfizer, Inc. recently launched a clinical trial of an over-the-counter (OTC) version of Lipitor. According to...

Genetic Mutation Found That Lowers Odds Of Developing Diabetes
2014-03-03 13:18:59

Brett Smith for redOrbit.com - Your Universe Online A massive new study from a team of international researchers has identified mutations in a gene that can significantly reduce the risk of developing type 2 diabetes – regardless of risk factors such as old age and being overweight. Seen in patients from multiple ethnic groups, the results showed a drug that imitates the influence of these mutations could be effectively used around the world. In the study published in Nature Genetics...

2014-03-03 12:26:21

Guests Support JDRF with Paper Sneaker Sales Through March 19 NEW ALBANY, Ohio, March 3, 2014 /PRNewswire/ -- This year, Bob Evans Farms is partnering with JDRF for the second year, with a goal of raising $100,000 for T1D research by selling JDRF's signature paper sneakers in each of its 561 restaurants. To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/65919-bob-evans-farms-fight-against-type-1-diabetes-t1d-jdrf-partnership...

2014-03-03 12:26:15

ST. PAUL, Minn., March 3, 2014 /PRNewswire/ -- Data Sciences International (DSI) announced today that Nova Biomedical (Nova) and DSI have signed a supply agreement for the development and manufacture of a fully implanted telemetry device for the continuous measurement of blood glucose in animal research applications. http://photos.prnewswire.com/prnvar/20140107/CG40863LOGO The Centers for Disease Control and Prevention (CDC) estimates that diabetes affects 26 million people in the U.S....

2014-03-03 08:32:04

Podium Presentation Highlighting Safety and Efficacy Data to be Presented by the Company's CSO, Dr. Miriam Kidron JERUSALEM, March 3, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be presenting detailed results from its recently completed Phase 2a FDA trial on ORMD-0801, its orally ingestible insulin capsule...

2014-03-03 08:31:14

PHILADELPHIA, March 3, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Robert F. Doman, Executive Chairman and Interim CEO of Echo Therapeutics, will present at the upcoming 26(th) Annual ROTH Capital Conference. Mr. Doman will make a corporate presentation to prospective corporate partners and investors at 8:00...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »